MEDIPHARM LABS CORP revenue for the last year amounted to 45.20 M CAD, the most of which — 17.64 M CAD — came from its highest performing source at the moment, International Medical Cannabis, the year earlier bringing 9.66 M CAD. The greatest contribution to the revenue figure was made by Canada — last year it brought MEDIPHARM LABS CORP 24.15 M CAD, and the year before that — 23.09 M CAD.